Novartis CEO Says New Purchases Will Boost Sales

Novartis CEO Says New Purchases Will Boost Sales Play

April 22 (Bloomberg) -- Novartis AG Chief Executive Officer Joe Jimenez talks about the agreement to buy GlaxoSmithKline Plc’s cancer-drug business for as much as $16 billion, forming a consumer-health venture with Glaxo and selling its animal-health operation to Eli Lilly & Co. for $5.4 billion. He speaks from Basel, Switzerland, with Mark Barton and Anna Edwards on Bloomberg Television's "Countdown." (Source: Bloomberg)

  • On Air Now

    The Pulse Watch Now

  • Next

    Bloomberg Surveillance

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus